8 Sources
[1]
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
SAN FRANCISCO, June 18 (Reuters) - SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia (NVDA.O), opens new tab, on Wednesday released a trove of data it hopes will speed up the discovery of new medical treatments by helping scientists understand how
[2]
5 million synthetic drug models could revolutionize pharma pipelines
"This is a long-standing problem in biology that we've all, as an industry, been trying to solve for," Nadia Harhen, general manager of AI simulation at SandboxAQ, told Reuters. "All of these computationally generated structures are tagged to a ground-truth experimental data, and so when you pick
[3]
This NVIDIA-Backed AI Startup Could Change the Way We Discover New Drugs | AIM
With a $150 million boost in funding, the company aims to integrate advanced AI models with extensive datasets into the drug development process. SandboxAQ, a startup focused on AI that emerged from Alphabet's Google and is supported by NVIDIA, released a large set of data recently aimed at
[4]
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
SandboxAQ, an AI startup originating from Alphabet's Google and backed by Nvidia, has released a substantial dataset to accelerate drug discovery. Generated using Nvidia's chips, the 5.2 million synthetic three-dimensional molecules aim to predict drug-protein binding. This data, validated by
[5]
SandboxAQ Launches Dataset for Training AI Models in Drug Discovery | PYMNTS.com
By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions. The SAIR (Structurally Augmented IC50 Repository) is a detailed dataset of
[6]
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
SAN FRANCISCO -- SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia, on Wednesday released a trove of data it hopes will speed up the discovery of new medical treatments by helping scientists understand how drugs stick to proteins. The goal is to help
[7]
SandboxAQ releases AI data to speed up drug discovery By Investing.com
Investing.com -- Artificial intelligence startup SandboxAQ released a large dataset on Wednesday aimed at accelerating drug discovery by helping scientists predict how drugs bind to proteins in the human body. The company, which spun out of Alphabet (NASDAQ:GOOGL)'s Google and has raised nearly $1
[8]
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
SAN FRANCISCO (Reuters) -SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia, on Wednesday released a trove of data it hopes will speed up the discovery of new medical treatments by helping scientists understand how drugs stick to proteins. The goal is
Share
Copy Link
SandboxAQ, an AI startup backed by Nvidia, has released a dataset of 5.2 million synthetic 3D molecules to speed up drug discovery by predicting how drugs bind to proteins.
SandboxAQ, an artificial intelligence startup spun out of Alphabet's Google and backed by Nvidia, has released a massive dataset aimed at revolutionizing the drug discovery process. The company has generated 5.2 million synthetic three-dimensional molecules using Nvidia's chips, with the goal of helping scientists predict how drugs bind to proteins in the human body
1
.
Source: BNN
The newly released dataset, named SAIR (Structurally Augmented IC50 Repository), includes detailed information on protein-ligand pairs with annotated experimental potency data. This comprehensive collection is designed to enhance the speed and accuracy of binding affinity predictions, a crucial step in the drug discovery process
5
.While the data is backed by real-world scientific experiments, it was not obtained from traditional laboratory settings. Instead, SandboxAQ utilized existing experimental data to calculate these new, "synthetic" three-dimensional molecules using equations based on real-world data. This approach combines traditional scientific computing techniques with recent advancements in AI
1
.The synthetic data released by SandboxAQ can be used to train AI models that predict whether a new drug molecule is likely to bind to the targeted protein. This process is estimated to be at least 1,000 times faster than traditional physics-based methods while maintaining accuracy
5
.
Source: Interesting Engineering
SandboxAQ, which has raised nearly $1 billion in venture capital, aims to integrate advanced AI models with extensive datasets into the drug development process. The company recently secured $150 million from investors including Google, NVIDIA, and BNP Paribas, bringing its total funding to $950 million
3
.Related Stories
This breakthrough could significantly impact the pharmaceutical industry by virtually replicating lab results and saving valuable time in the drug discovery process. Nadia Harhen, general manager of AI simulation at SandboxAQ, stated, "This achievement marks a pivotal moment in drug discovery, demonstrating our capacity to fundamentally transform the traditional trial-and-error process into a rapid, data-driven approach"
5
.
Source: PYMNTS
The merger of AI with quantum computing could have significant implications for many verticals, including drug discovery. As Chris Hume, senior director of business operations for SandboxAQ, explained, "The physical world is defined by quantum mechanics. The more effectively we can understand those interactions and then model those interactions, the more efficiently and effectively you can build predictive models"
5
.Summarized by
Navi
[2]
04 Apr 2025•Technology

29 Oct 2024•Science and Research

30 Jun 2026•Technology

1
Science and Research

2
Policy and Regulation

3
Technology